MEET
SARAH & MISSY

Meningitis B didn’t just change Sarah’s future. It changed her family’s future as well.

THE DECISION IS YOURS:

  • CHOICE

    “It’s rare. Do I vaccinate for meningitis B or not?”

    CDC recommends meningococcal serogroup B (meningitis B) vaccination for adolescents not at increased risk, aged 16–23 years (preferred age 16–18 years), based on shared clinical decision-making.1,2

     

    “Should I bring up meningitis B during the wellness visit?”

    Yes, it’s important to have a discussion about vaccinations with patients and their parents. In its Immunization Schedules, CDC recommends meningitis B vaccination for adolescents not at increased risk age 16–23 years (preferred age 16–18 years) based on shared clinical decision-making.1-3

     

    Vaccination may not protect all recipients.

  • CHANCE

    View Video Transcript

    “It was difficult to learn how to do things I had done my entire life. Again.”

    — Sarah

 

Sarah is a survivor of meningococcal disease and not a healthcare provider. She and her mother, Missy, were compensated by GSK for their participation in this program. This is their experience with meningococcal disease; others’ experiences may be different.

 

Vaccination may not protect all recipients.

References:

1. Recommended child and adolescent immunization schedule for ages 18 years or younger United States 2022. Centers for Disease Control and Prevention. Reviewed February 17, 2022. Accessed May 26, 2022. https://www.cdc.gov/vaccines/schedules/hcp/imz/child-adolescent.html

2. Recommended adult immunization schedule for ages 19 years or older, United States 2022. Centers for Disease Control and Prevention. Reviewed February 17, 2022. Accessed May 26, 2022. https://www.cdc.gov/vaccines/schedules/hcp/imz/adult.html#notes

3. Meningococcal vaccination: recommendations of the Advisory Committee on Immunization Practices, United States, MMWR 2020;69(9):1-44.